UroToday.com (@urotoday) 's Twitter Profile
UroToday.com

@urotoday

Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology

ID: 21319494

calendar_today19-02-2009 17:36:50

118,118K Tweet

28,28K Takipçi

6,6K Takip Edilen

UroToday.com (@urotoday) 's Twitter Profile Photo
UroToday.com
@urotoday

2 months ago

#ESMO24 #QuickTake Insights: The #ARANOTE trial showcases darolutamide + ADT's efficacy in #mHSPC, with a 46% reduction in rPFS risk. This phase III trial highlights darolutamide's potential as a tolerable alternative to ADT monotherapy, showing significant benefits, especially

#ESMO24 #QuickTake Insights: The #ARANOTE trial showcases darolutamide + ADT's efficacy in #mHSPC, with a 46% reduction in rPFS risk. This phase III trial highlights darolutamide's potential as a tolerable alternative to ADT monotherapy, showing significant benefits, especially